Back to resultsInvitro Maturation of Oocytes for Patients With Polycystic Ovaries
Primary Purpose
Infertility, Polycystic Ovaries
Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
in vitro matuartion of oocytes
Sponsored by
About this trial
This is an interventional treatment trial for Infertility focused on measuring in vitro maturation oocytes
Eligibility Criteria
Inclusion Criteria:
- Polycystic ovaries
- Needing IVF for fertility treatment
Exclusion Criteria:
- Age above 39
Sites / Locations
- IVF and Infertility Unit, Assaf Harofeh Medical Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Group I
Arm Description
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Outcomes
Primary Outcome Measures
maturation rate,
Secondary Outcome Measures
Fertilization rate, pregnancy rate
Full Information
NCT ID
NCT00631982
First Posted
March 3, 2008
Last Updated
March 7, 2008
Sponsor
Assaf-Harofeh Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00631982
Brief Title
Invitro Maturation of Oocytes for Patients With Polycystic Ovaries
Official Title
In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries
Study Type
Interventional
2. Study Status
Record Verification Date
March 2008
Overall Recruitment Status
Unknown status
Study Start Date
April 2008 (undefined)
Primary Completion Date
October 2009 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Assaf-Harofeh Medical Center
4. Oversight
5. Study Description
Brief Summary
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, Polycystic Ovaries
Keywords
in vitro maturation oocytes
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group I
Arm Type
Experimental
Arm Description
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Intervention Type
Procedure
Intervention Name(s)
in vitro matuartion of oocytes
Intervention Description
in vitro maturation of (immature) oocytes
Primary Outcome Measure Information:
Title
maturation rate,
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Fertilization rate, pregnancy rate
Time Frame
18 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Polycystic ovaries
Needing IVF for fertility treatment
Exclusion Criteria:
Age above 39
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Raphael Ron - El, MD
Phone
+972-8-9779005
Facility Information:
Facility Name
IVF and Infertility Unit, Assaf Harofeh Medical Center
City
Zerifin
ZIP/Postal Code
70300
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Raphael Ron-El, MD
Phone
+972-8-9779005
First Name & Middle Initial & Last Name & Degree
Raphael Ron - El, MD
12. IPD Sharing Statement
Learn more about this trial
Invitro Maturation of Oocytes for Patients With Polycystic Ovaries
We'll reach out to this number within 24 hrs